Interpretation on 2013 updated Chinese Consensus on the Diagnosis and Treatment of Gastrointestinal Stromal Tumors.
- Author:
Lin SHEN
1
Author Information
1. Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing 100142, China. lin100@medmail.com.cn.
- Publication Type:Journal Article
- MeSH:
Consensus;
Diagnosis, Differential;
Genotype;
Humans;
Neoplasms;
diagnosis
- From:
Chinese Journal of Gastrointestinal Surgery
2014;17(4):305-308
- CountryChina
- Language:Chinese
-
Abstract:
The Gastrointestinal Stromal Tumor Experts Committee amended and complemented the Chinese Consensus on the Diagnosis and Treatment of Gastrointestinal Stromal Tumors(2013 version) based on the previous edition(2011 version) after broad consulation, repeat discussion on new results of clinical trials in recent years and the opinions of many experts. In the new consensus, the pathological diagnose was revised the most, including definition, diagnosis differential diagnosis, genotype, and recurrence risk classification. However, few modifications was made in surgical treatment and targeted therapy. It also describes the characteristics and difference between Chinese consensus and NCCN guideline so as to be more succinct as the reference of clinical practice and more suitable for Chinese patients. This article interpreted the key points of the update.
